Fermented Perilla frutescens Ameliorates Depression-like Behavior in Sleep-Deprivation-Induced Stress Model
Open Access
- 30 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 622
Abstract
Excessive stress plays a critical role in the pathogenesis of mood disorders such as depression. Fermented natural products have recently attracted attention because of their health benefits. We evaluated the antidepressant-like efficacy of fermented Perilla frutescens (FPF), and its underlying mechanisms, in sleep deprivation (SD)-induced stress mice. SD-stressed mice revealed a remarkable increase in the immobility time in both forced swimming test and tail suspension test; this increase was ameliorated by treatment with FPF at doses of 100 and 150 mg/kg. FPF treatment also reduced the level of stress hormones such as corticosterone and adrenocorticotropic hormone. Additionally, FPF increased the levels of serotonin and dopamine which were significantly decreased in the brain tissues of SD-stressed mice. The increased expression of proinflammatory cytokines, such as TNF-α and IL1β, and the decreased expression of brain-derived neurotrophic factor (BDNF) in the stressed mice were significantly reversed by FPF treatment. Furthermore, FPF also increased phosphorylation of tropomyosin receptor kinase B (TrkB), extracellular regulated protein kinase (ERK), and cAMP response element binding protein (CREB). Among the six components isolated from FPF, protocatechuic acid and luteolin-7-O-glucuronide exhibited significant antidepressant-like effects, suggesting that they are major active components. These findings suggest that FPF has therapeutic potential for SD-induced stress, by correcting dysfunction of hypothalamic-pituitary-adrenal axis and modulating the BDNF/TrkB/ERK/CREB signaling pathway.Keywords
Funding Information
- Ministry of Science and ICT (MSIT) (2020-JDH-3-CG-1)
- Korean government (MSIT) (NRF2021M3H1A104892211)
- Ministry of Food and Drug Safety (21153MFDS602)
This publication has 96 references indexed in Scilit:
- Antidepressant-like activity of turmerone in behavioral despair tests in miceBMC Complementary and Alternative Medicine, 2013
- Total Antioxidant Capacity and Malondialdehyde in Depressive Rotational Shift WorkersJournal of Environmental and Public Health, 2013
- The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?Psychoneuroendocrinology, 2011
- Health effects of omega-3,6,9 fatty acids: Perilla frutescens is a good example of plant oilsOriental Pharmacy & Experimental Medicine, 2011
- Contributions of ERK signaling in the striatum to instrumental learning and performanceBehavioural Brain Research, 2011
- Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral ModelsNeuropsychopharmacology, 2010
- Adverse metabolic and cardiovascular consequences of circadian misalignmentProceedings of the National Academy of Sciences, 2009
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatmentMolecular Psychiatry, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoidsProceedings of the National Academy of Sciences, 2006